Yoga on Arrhythmia Burden and Quality of Life in Paroxysmal Atrial Fibrillation

Atrial Fibrillation Clinical Trial

Official title:

The Effect of Yoga on Arrhythmia Burden and Quality of Life in Patients With Paroxysmal Atrial Fibrillation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00798356
• Other study ID #: 11067
• Status: Completed
• Phase: N/A
• First received: November 25, 2008
• Last updated: June 13, 2012
• Start date: November 2008
• Est. completion date: January 2012

Study information

• Verified date: June 2012
• Source: University of Kansas Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

Studies in the past have shown that yoga could relieve stress which is the most common trigger for recurrent episodes of atrial fibrillation. Breathing exercises in yoga are found to influence the autonomic nervous system (particularly parasympathetic) and thus reduce palpitations. This study hypothesizes that patients with atrial fibrillation might benefit by practicing yoga. Yoga may also help to better control heart rate and rhythm when used in combination with usual medical management.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 84
• Est. completion date: January 2012
• Est. primary completion date: January 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 25 Years to 80 Years

Eligibility

Inclusion Criteria:

• Patients diagnosed with paroxysmal atrial fibrillation ages 25-80

Exclusion Criteria:

• Advanced malignancy or severe co-morbid conditions such as severe heart failure and with life expectancy less than 1 year

• Pregnant women

• Unmedicated or uncontrolled high blood pressure

• A past history of pneumothorax

• Severe cervical spondylitis and cervical, thoracic or lumbar disc prolapse

• Carotid stenosis

• History of psychosis or substance abuse

• History of epilepsy

• Glaucoma

• History of total hip replacement

• Ablation within 3 months of the start date of study

• Patients who have not seen a cardiovascular physician in the last year

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Atrial Fibrillation

Intervention

Other:
• Yoga training
Yoga training for 12 weeks

Locations

Country	Name	City	State
United States	University of Kansas Medical Center	Kansas City	Kansas

Sponsors (1)

Lead Sponsor	Collaborator
Dhanunjaya Lakkireddy, MD, FACC

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	frequency and duration of atrial fibrillation episodes		12 weeks	No